- Home
- RDHL vs KAVL Comparison
RDHL vs KAVL Comparison
Compare RDHL & KAVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- KAVL
- Stock Information
- Founded
- RDHL 2009
- KAVL 1998
- Country
- RDHL Israel
- KAVL United States
- Employees
- RDHL N/A
- KAVL N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- KAVL Medicinal Chemicals and Botanical Products
- Sector
- RDHL Health Care
- KAVL Health Care
- Exchange
- RDHL Nasdaq
- KAVL Nasdaq
- Market Cap
- RDHL 3.9M
- KAVL 9.6M
- IPO Year
- RDHL N/A
- KAVL N/A
- Fundamental
- Price
- RDHL $1.52
- KAVL $0.67
- Analyst Decision
- RDHL
- KAVL
- Analyst Count
- RDHL 0
- KAVL 0
- Target Price
- RDHL N/A
- KAVL N/A
- AVG Volume (30 Days)
- RDHL 43.0K
- KAVL 293.7K
- Earning Date
- RDHL 09-05-2025
- KAVL 09-11-2025
- Dividend Yield
- RDHL N/A
- KAVL N/A
- EPS Growth
- RDHL N/A
- KAVL N/A
- EPS
- RDHL N/A
- KAVL N/A
- Revenue
- RDHL $9,550,000.00
- KAVL $1,698,426.00
- Revenue This Year
- RDHL $381.91
- KAVL N/A
- Revenue Next Year
- RDHL N/A
- KAVL N/A
- P/E Ratio
- RDHL N/A
- KAVL N/A
- Revenue Growth
- RDHL 157.62
- KAVL N/A
- 52 Week Low
- RDHL $1.06
- KAVL $0.45
- 52 Week High
- RDHL $11.70
- KAVL $1.95
- Technical
- Relative Strength Index (RSI)
- RDHL 52.49
- KAVL 42.77
- Support Level
- RDHL N/A
- KAVL $0.64
- Resistance Level
- RDHL $1.60
- KAVL $0.72
- Average True Range (ATR)
- RDHL 0.07
- KAVL 0.10
- MACD
- RDHL -0.02
- KAVL -0.04
- Stochastic Oscillator
- RDHL 95.00
- KAVL 6.70
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About KAVL Kaival Brands Innovations Group Inc.
Kaival Brands Innovations Group Inc is focused on growing and incubating creative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.